QTREX Quantum Ltd. (QTEX)
Nasdaq · Technology · Computer Hardware
$1.54+40.00%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $103M
- 52-week range
- $0.283 – $3.85
- 52-week change
- −4.35%
- EPS (trailing)
- −$0.35
Fiscal year to Dec 2025
- Revenue
- $289K
- Net income
- −$13.2M
- Operating margin
- −4713.8%
- Diluted EPS
- −$0.45
- Free cash flow
- −$10.0M
From the company’s annual report on SEC EDGAR.
About QTREX Quantum Ltd.
QTREX Quantum Ltd., engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure and advanced connectivity solutions for the quantum computing industry in Israel and USA. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers HYLA blood sensor, which is designed to perform real-time sampling and analysis of key blood parameter measurements. In addition, The company offers cryogenic interconnects systems are generally built from multiple discrete components assembled and verified in a manual process. It also develops a monolithic interconnect architecture that integrates the conductor, radio-frequency dielectric, shielding, thermal management, and mechanical routing into a single engineered structure, designed to replace discrete, manually assembled cabling and support higher channel density and reliability.
Headquarters: Ra'anana, Israel · 34 employees · q-trex.com